Does Dr. EAHAB ABDUL-LATTIF have financial conflicts of interest?

Dr. EAHAB ABDUL-LATTIF (M.D) has received a total of $116 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $116 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. EAHAB ABDUL-LATTIF?

According to CMS Open Payments data, Dr. EAHAB ABDUL-LATTIF received funding from JANSSEN PHARMACEUTICALS ($43), ZOLL SERVICES (A/K/A ZOLL LIFECOR ) ($21), and XERIS PHARMACEUTICALS ($19).

Does Dr. EAHAB ABDUL-LATTIF receive research grants or speaking fees?

Dr. EAHAB ABDUL-LATTIF has received $116 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. EAHAB ABDUL-LATTIF

M.DReal-Time Hydrated

Specialty: Internal Medicine

Practice Location: BRISTOL, PA 19007

NPI Number: 1881219863

LIFETIME INDUSTRY VALUE

$116

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABDUL-LATTIF is a verified Internal Medicine practitioner based in BRISTOL, PA.

Between 2021 and 2024, Dr. ABDUL-LATTIF had an overall industry promotional and research financial footprint of $116 as recorded in the federal CMS Open Payments database.

$116 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDUL-LATTIF's primary funding source is JANSSEN PHARMACEUTICALS, which accounts for $43 (representing 37% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JANSSEN PHARMACEUTICALS

Rank 1

$43

37%

ZOLL SERVICES (A/K/A ZOLL LIFECOR )

Rank 2

$21

18.1%

XERIS PHARMACEUTICALS

Rank 3

$19

16.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.